Who makes [18F]-FET-βAG-TOCA?

[18F]-FET-βAG-TOCA is developed by Imperial College London.

What development phase is [18F]-FET-βAG-TOCA in?

[18F]-FET-βAG-TOCA is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[18F]-FET-βAG-TOCA

Imperial College London · Phase 1 active Small molecule

At a glance

Generic name	[18F]-FET-βAG-TOCA
Sponsor	Imperial College London
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]-FET-βAG-TOCA CI brief — competitive landscape report
[18F]-FET-βAG-TOCA updates RSS · CI watch RSS
Imperial College London portfolio CI